AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06181981 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: MRI fingerprinting
Description: This method allows to get quantitative magnetic resonance imaging for the simultaneous measurement of multiple tissue properties in a single, time-efficient acquisition
Study NCT05602285 — intervention group
Intervention type: DEVICE
Intervention: Dislodgement device
Description: Breakaway device that prevents IV dislodgement
Study NCT05156411 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: eccentric arm-cranking training
Description: Over the twenty training sessions, able-bodied participants will exercise on the KREHA device. An arm-crank has to be decelerated, which will be rotated by a prematurely defined revolution rate and training duration. During this intervention a certain power has to be applied. During the whole time of training a continous progression in power and training duration is applied
Study NCT05317702 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Moderately Painful Massage
Description: Participants will be seated in a chair with his or her shirt on. Participants will receive 60 seconds of manual pressure applied to the myofascial trigger point identified in the participant's upper back. The researcher's thumb or index finger will apply a deep manual pressure such that the participant rates the pain = 50/100 on a 101-point numeric pain rating scale with 0 indicating no pain and 100 indicating the most severe pain imaginable. The participant will be asked to rate his or her pain during the massage so the pressure may be adjusted to maintain the 50/100 related pain. Massage will be applied for 60 seconds, 4 times for a total contact time of 240 seconds. During each 30 second break in which manual pressure is released, Pressure Pain Threshold (PPT) to the foot will be examined. PPT will be assessed 2 times immediately after each of the 4 massage applications.
Study NCT05032638 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Upper extremity (UE) Training
Description: The 4-week UE training is completed in the participants home on their own and communication with study staff is virtual. Participants will receive daily communication through the Expiwell app to answer survey questions related to adherence, and safety/adverse events. Participants will also complete weekly check-ins with their research therapist over Zoom to answer questions about difficulties related to UE training activities, refinement of training goals, and to receive feedback on their training performance. Each weekly check-in will be approximately 45 minutes.
Study NCT06242847 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Oral glucose tolerance test (OGTT)
Description: Participants ingest 75 g of glucose in 10 fl oz aqueous solution (fruit flavored) after an overnight fast. Blood is drawn at baseline (t = 0 min) and at 120 min after ingestion. This test is non-experimental.
Study NCT06242847 — intervention group
Intervention type: PROCEDURE
Intervention: Skin punch biopsy
Description: Punch biopsies are taken from lesional (psoriatic) and non-lesional skin after an overnight fast and at 120 min after ingestion of glucose during OGTT. This procedure is non-experimental.
Study NCT04943172 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hancock-Jaffe bioprosthetic venous valve (VenoValve®)
Description: Surgical implantation of the VenoValve device
Study NCT05296408 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: motor learning based therapy
Description: Motor learning based therapy will include functional task/task component training and will be employed to practice hand-to-mouth, forward reach, grasp-release, and object manipulation. Training will include high repetition both in the clinic and during home exercise practice. Tasks will be decomposed into component parts and practiced in this manner with the goal of returning to full task performance as skill develops Training will be tailored to each individual subject's capability and progressed according to a motor control hierarchy to ensure adequate challenge. Training is always started at the appropriate level of challenge for an individual to ensure adequate challenge is delivered whether the individual is higher or lower functioning.
Study NCT05296408 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: motor learning based therapy
Description: Motor learning based therapy will include functional task/task component training and will be employed to practice hand-to-mouth, forward reach, grasp-release, and object manipulation. Training will include high repetition both in the clinic and during home exercise practice. Tasks will be decomposed into component parts and practiced in this manner with the goal of returning to full task performance as skill develops Training will be tailored to each individual subject's capability and progressed according to a motor control hierarchy to ensure adequate challenge. Training is always started at the appropriate level of challenge for an individual to ensure adequate challenge is delivered whether the individual is higher or lower functioning.
Study NCT05296408 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MyoPro
Description: The MyoPro supports motor learning-based training by reinforcing coordinated movement practice, allowing for finely incrementalized training progression, and encouraging high repetition of movement. Importantly, the device assists the user to move the paretic limb in a manner they may otherwise be unable to do. This further motivates the user to continue attempts to move the paretic limb. When a user attempts to volitionally contract a weak muscle, sensors embedded within the MyoPro detect the EMG signal, which triggers activation of a motor within the device. The motor assists the user to complete the desired movement (e.g. opening of the hand).Subjects experience real-time biofeedback through their ability to sense and see movement of the target joint(s) and via their interface with the software on a computer that provides visual feedback of the EMG level of the contracting muscle
Study NCT05296408 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home Exercise Program
Description: Every subject will be assigned an individualized HEP. Therapy staff will create written handouts for the user to follow. The HEP will include photographs of the study participant performing his/her exercises/functional tasks along with written instructions. Each individual will have their own personalized HEP that will be created during their study participation and will be dispensed only to them. The HEP will reinforce in-clinic therapy. The HEP will be progressed regularly, and individuals will log practice time. The HEP for M+ML will include practice with and without the MyoPro; the HEP for ML-alone will include practice without MyoPro. Each HEP session will require approximately 90 minutes to complete.
Study NCT05296408 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Home Exercise Program
Description: Every subject will be assigned an individualized HEP. Therapy staff will create written handouts for the user to follow. The HEP will include photographs of the study participant performing his/her exercises/functional tasks along with written instructions. Each individual will have their own personalized HEP that will be created during their study participation and will be dispensed only to them. The HEP will reinforce in-clinic therapy. The HEP will be progressed regularly, and individuals will log practice time. The HEP for M+ML will include practice with and without the MyoPro; the HEP for ML-alone will include practice without MyoPro. Each HEP session will require approximately 90 minutes to complete.
Study NCT04740060 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Augmented Feedback without Virtual Reality(VR
Description: For Walking Speed:One-minute fast walking with visual augmented feedback without VR interface (we ask participants to look at a screen where their walking speed and distance are tracked and increase their speed).~For Step Length: Maximum step length with visual augmented feedback without VR interface in which we ask participants to look at a screen where their step length is displayed and attempt to increase their step length up.
Study NCT04740060 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Augmented Feedback with Non-Game based VR
Description: For Walking Speed:One-minute fast walking with basic VR interface (we ask participants to look at a screen where their avatar walker representative will be represented in a virtual walking environment and try to make the avatar walk faster).~For Step Length: Maximum step length with basic VR interface in which we ask participants to look at their avatar feet in a virtual stepping environment and step with the avatar foot as far as possible.
Study NCT04740060 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Augmented Feedback with Game based VR
Description: For Walking Speed: One-minute fast walking with the VR Racing exergame (we ask participants to look at a screen where their avatar walker representative present in a virtual racing environment with other avatar racers and try to beat the avatar racers).~For Step Length: Maximum step length with the VR Stepping Exergame (we ask participants to look at their avatar legs and avatar animals in a virtual stepping environment and try to step over the avatar animals without touching the animal.
Study NCT06338046 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Corthellus Shiitake(Mushroom) Extract
Description: topical treatment with Corthellus Shiitake(Mushroom) Extract
Study NCT06338046 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: topical treatment with a placebo cosmetic formula
Study NCT04995692 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telehealth Education for Asthma Connecting Hospital and Home
Description: TEACHH aims to provide educational support to families managing childhood asthma throughout the transition from hospital to home, and includes several core components: 1) Health literacy-informed inpatient teaching for child and caregiver including pictorial materials, hands-on demonstration, and use of teach-back/show-back techniques; 2) Facilitated identification of rescue and controller medications using color- and shape-coded medication labels and a pictorial asthma action plan; and 3) A pair of virtual follow-up visits after discharge to reinforce inpatient teaching and support families during the shift from acute exacerbation to preventive care management. Virtual visits will be completed using the Zoom platform on smartphones or other compatible devices, 2-4 days after discharge (first visit) and 3 weeks after discharge (second visit). All intervention activities will be completed within 1 month of discharge.
Study NCT04995692 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Care (SC) Comparison Group
Description: Patients in the SC group will receive standard impatient management, including pre-recorded asthma education videos shown prior to discharge and the hospital action plan. PCP follow-up with be scheduled within a week of discharge. All SC measures will also be provided to subjects randomized to TEACHH.
Study NCT05056766 — intervention group
Intervention type: BEHAVIORAL
Intervention: questionnaires: Epworth Sleepiness Scale; Pichot fatigue questionnaire.
Description: Each patient will undergo 3 to 7 polygraphy recordings according usual practice of titration At the same time, Self-questionnaires will be conducted by the patient in order to evaluate Oral appliance efficacy.~Optimal titration of oral appliance will be done according subjectives parameters. (sleepeness Reduction and fatigue Reduction).~Neither the investigator nor the patient will know the polygraphy results (apnea-hypopnea index)
Study NCT05135351 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Resistant Starch
Description: A prebiotic nutritional supplement available at commercial grocery and health food stores. Specifically, we will be using Bob's Red Mill® potato starch.
Study NCT05853185 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pro Root MTA®
Description: Patients in this group will receive the pulpotomy with Pro Root MTA®.
Study NCT05135351 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Maltodextrin
Description: A starch commonly used as a placebo in prebiotic trials that is digested in the stomach and rapidly absorbed
Study NCT05187260 — intervention group
Intervention type: DRUG
Intervention: Nusinersen
Description: SPINRAZA® (nusinersen) prescribed as part of standard of care
Study NCT06375980 — intervention group
Intervention type: OTHER
Intervention: Intraoperative Mechanical Ventilation Strategies
Description: The intervention involves the management of mechanical ventilation during major abdominal surgery. This includes the adjustment of ventilation parameters such as tidal volume, respiratory rate, peak pressure, positive end-expiratory pressure (PEEP), and inspiratory flow rate. The aim is to optimize ventilation strategies to reduce the risk of postoperative pulmonary complications
Study NCT05121909 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Colgate (R) Cavity Protection Toothpaste
Description: Participants will use Colgate (R) Cavity Protection Toothpaste for brushing teeth twice daily.
Study NCT05121909 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Colgate (R) Cavity Protection Toothpaste
Description: Participants will use Colgate (R) Cavity Protection Toothpaste for brushing teeth twice daily.
Study NCT05121909 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Colgate (R) Cello Toothbrush
Description: Participants will use Colgate (R) Cello Toothbrush for brushing teeth twice daily.
Study NCT05121909 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Colgate (R) Cello Toothbrush
Description: Participants will use Colgate (R) Cello Toothbrush for brushing teeth twice daily.
Study NCT05121909 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prototype 1 Mouthwash
Description: Participants will use 20 mL of Prototype 1 Mouthwash for 30 seconds after brushing twice daily.
Study NCT05121909 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prototype 2 Mouthwash
Description: Participants will use 20 mL of Prototype 2 Mouthwash for 30 seconds after brushing twice daily.
Study NCT05121909 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prototype 3 Mouthwash
Description: Participants will use 20 mL of Prototype 3 Mouthwash for 30 seconds after brushing twice daily.
Study NCT05121909 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Listerine (R) Cool Mint (R) Antiseptic Mouthwash
Description: Participants will use 20 mL of Listerine (R) Cool Mint (R) Antiseptic Mouthwash for 30 seconds after brushing twice daily.
Study NCT05121909 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 5% Hydroalcohol Mouthwash
Description: Participants will use 20 mL of 5% Hydroalcohol Mouthwash for 30 seconds after brushing twice daily.
Study NCT05757089 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: ALCOFILTRUM
Description: ALCOFILTRUM helps alleviate alcohol hangover symptoms after a single intake for 30 minutes before alcohol consumption.
Study NCT06259864 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EXOPULSE Mollii Suit method
Description: EXOPULSE Mollii Suit method, one of the newest rehabilitation technology products, is a non-invasive neuromodulation approach with a garment that covers the whole body and electrodes placed inside. Designed to improve motor function by reducing spasticity and pain, the method is based on the principle of reciprocal inhibition, which occurs by stimulating the antagonist of a spastic muscle at low frequencies and intensities.
Study NCT06259864 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: EXOPULSE Mollii Suit method
Description: EXOPULSE Mollii Suit method, one of the newest rehabilitation technology products, is a non-invasive neuromodulation approach with a garment that covers the whole body and electrodes placed inside. Designed to improve motor function by reducing spasticity and pain, the method is based on the principle of reciprocal inhibition, which occurs by stimulating the antagonist of a spastic muscle at low frequencies and intensities.
Study NCT04800393 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Description: induction of anesthesia with propofol, maintenance of anesthesia with sevoflurane during breast cancer surgery
Study NCT04800393 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol
Description: propofol-based total intravenous anesthesia during breast cancer surgery
Study NCT05818826 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: normal saline solution
Description: Prepare 100 ml of normal saline solution, packed out in the same format, dose, and administration of the drug were exactly the same as in the conventional cessation group.
Study NCT05818826 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Hydrocortisone and normal saline solution
Description: Prepare hydrocortisone with normal saline solution 100 ml starts dose at least 200 mg/day according to doctor's order after patient meets the criteria of refractory septic shock then continues conventional cessation of hydrocortisone according to doctor's order after required dose of vasopressor less than 0.1 mcg/kg/min.
Study NCT06481657 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: train with oxygen and without oxygen enrichment (placebo).
Description: The experimental group will train with oxygen goggles in the aerobic part of the training The control group will train with oxygen goggles without oxygen enrichment (placebo).
Study NCT06481657 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: train with oxygen and without oxygen enrichment (placebo).
Description: The experimental group will train with oxygen goggles in the aerobic part of the training The control group will train with oxygen goggles without oxygen enrichment (placebo).
Study NCT05137886 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PD-1 inhibitor
Description: decitabine 10mg on d1-5, Tislelizumab 200mg on d8，21 days as one cycle.
Study NCT05929885 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Low Dose OXIRI (LD-OXIRI)
Description: The LD-OXIRI regimen will be administered in the following sequence:~* metronomic capecitabine (Xeloda; X) 650mg/m2 will administered twice a day on a daily a continuous basis;~* intravenous metronomic oxaliplatin (O) 50 mg/m2 will be infused over 120 minutes on days 1 and 8 of a 21 day-cycle; followed by~* intravenous irinotecan (I) will be infused over 90 minutes on days 1 and 8 of a 21 day-cycle. The dose of irinotecan will be based on the particular patient's UGT1A1\*6 and UGT1A1\*28 genotype status.
Study NCT05853185 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: EBRRM®
Description: Patients in this group will receive the pulpotomy with Endo Sequence Bioceramic Root Repair (EBRRM)®.
Study NCT05510609 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: BK 5000 Ultrasound Machine
Description: Both 2D and 3D ultrasound is being used. 3D using optical tracking.
Study NCT04469803 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intra-Shift Napping
Description: The Brief Nap opportunity will allow for a 30-minute nap between the hours of 0200 and 0400 during the 12-hour simulated night shift. The Longer Nap opportunity will allow for a 2-hour nap between the hours of 0200 and 0400 during the 12-hour simulated night shift.
Study NCT04720378 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ST266
Description: 1X ST266
Study NCT05450952 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Theanine Formulation
Description: Theanine Formulation Tablet
Study NCT05450952 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo Tablet
Study NCT06057636 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-Administered Hypnosis
Description: Participants will choose from one of three 20-minute prerecorded hypnosis audio files. Practices using the recordings will be documented on the hypnosis practice log.
Study NCT06057636 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Self-Administered White Noise Hypnosis
Description: Participants will be listening to the same 20-minute white noise audio recording for 6 weeks and will be encouraged to practice daily. Practices using the recordings will be documented on the hypnosis practice log.
Study NCT06183632 — intervention group
Intervention type: BIOLOGICAL
Intervention: blood sampling
Description: 3 x 7mL EDTA blood tubes
Study NCT05533398 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stress ball use
Description: They were asked to use the ball for at least 10 minutes during the dialysis treatment and when they felt stressed or unwell at home/work. Patients with arteriovenous fistula or arteriovenous graft were instructed to use the stress ball with the other hand, where there was no vascular access.
Study NCT06526455 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vonoprazan
Description: oral drug 3-56 days after ESD.
Study NCT06526455 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Esomeprazole
Description: oral drug 3-56 days after ESD.
Study NCT05094895 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Stretta
Description: Radiofrequency energy delivered to the gastro-esophageal junction
Study NCT05094895 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: Patients that have the sham condition will have a procedure using a 24Fr Savary bougie dilator over the guidewire, with the same sedation.
Study NCT05905757 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dexmedetomidin + bupivacaine
Description: dexmedetomidine was added as adjuvant to bupivacaine in transversus abdominis plane block (TAP)
Study NCT05905757 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tramadol + Bupivacaine
Description: tramadol was added as adjuvant to bupivacaine in transversus abdominis plane block (TAP)